Laurent Kaiser Selected Research

Laurent Kaiser Research Topics

Disease

47	Infections 12/2022 - 01/2002
23	COVID-19 10/2022 - 07/2020
12	Human Influenza (Influenza) 01/2022 - 07/2003
5	Viremia 01/2018 - 07/2004
4	Vesicular Stomatitis 12/2021 - 10/2015
4	Rhinosinusitis 01/2021 - 03/2002
4	Virus Diseases (Viral Diseases) 01/2020 - 10/2010
3	Pneumonia (Pneumonitis) 01/2022 - 01/2018
3	HIV Infections (HIV Infection) 01/2018 - 06/2004
2	Rheumatic Diseases (Rheumatism) 08/2022 - 06/2011
2	Communicable Diseases (Infectious Diseases) 01/2022 - 03/2005
2	Reinfection 08/2021 - 02/2021
2	Critical Illness (Critically Ill) 10/2020 - 08/2020
2	Respiratory Insufficiency (Respiratory Failure) 08/2020 - 03/2004
2	Fever (Fevers) 01/2020 - 09/2015
2	Neoplasms (Cancer) 01/2020 - 01/2012
2	Bacterial Infections (Bacterial Infection) 01/2020 - 01/2011
2	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 05/2016
2	Measles 01/2019 - 01/2019
2	Disease Progression 11/2018 - 08/2014
2	Inflammation (Inflammations) 01/2018 - 03/2013
2	Ebola Hemorrhagic Fever 04/2016 - 09/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2011 - 10/2010
2	Cytomegalovirus Infections (Inclusion Disease) 11/2002 - 01/2002
1	Multiple Sclerosis 08/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Bacterial Pneumonia 01/2022
1	Presbyopia 12/2021
1	Dizziness (Lightheadedness) 12/2021
1	Fatigue 12/2021
1	Anosmia 11/2021
1	Diphtheria 01/2021
1	Tetanus 01/2021
1	Cognitive Dysfunction 12/2020
1	Superinfection 10/2020
1	Aspergillosis 10/2020
1	Abscess 01/2020
1	Bacteremia 01/2020
1	Bites and Stings (Sting) 04/2019

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 12/2021 - 07/2004
15	Antiviral Agents (Antivirals)IBA 12/2021 - 08/2002
12	AntibodiesIBA 10/2022 - 01/2019
12	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 03/2002
9	Immunoglobulin G (IgG)IBA 02/2022 - 06/2011
6	Neutralizing AntibodiesIBA 12/2022 - 01/2021
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2010
5	RNA (Ribonucleic Acid)IBA 01/2018 - 06/2004
4	InterferonsIBA 12/2022 - 01/2020
4	CytokinesIBA 11/2021 - 12/2014
4	Immunoglobulin M (IgM)IBA 10/2020 - 06/2011
4	DNA (Deoxyribonucleic Acid)IBA 04/2007 - 11/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2022 - 01/2018
3	AntigensIBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2021
3	Oseltamivir (Tamiflu)FDA Link 02/2021 - 07/2003
3	Interferon LambdaIBA 01/2020 - 08/2014
3	Neuraminidase (Sialidase)IBA 01/2019 - 01/2011
2	AutoantibodiesIBA 10/2022 - 01/2018
2	Rituximab (Mabthera)FDA Link 08/2022 - 01/2012
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2019
2	Lopinavir FDA Link 12/2021 - 11/2020
2	Ritonavir (Norvir)FDA Link 12/2021 - 11/2020
2	Immunoglobulin A (IgA)IBA 11/2021 - 06/2011
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2021 - 10/2021
2	Complement System Proteins (Complement)IBA 10/2021 - 01/2011
2	Nucleic AcidsIBA 04/2021 - 03/2005
2	NucleoproteinsIBA 02/2021 - 01/2021
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2021 - 07/2004
2	C-Reactive ProteinIBA 01/2020 - 10/2010
2	Biological ProductsIBA 01/2018 - 09/2015
2	Glycoproteins (Glycoprotein)IBA 04/2016 - 10/2015
2	Viral RNAIBA 04/2016 - 01/2011
2	Interferon Type IIBA 09/2014 - 06/2012
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2012 - 06/2011
1	Messenger RNA (mRNA)IBA 08/2022
1	ocrelizumabIBA 08/2022
1	COVID-19 VaccinesIBA 08/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 12/2021
1	HDL LipoproteinsIBA 11/2021
1	Immunoglobulins (Immunoglobulin)IBA 02/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Combined VaccinesIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2020
1	remdesivirIBA 12/2020

Therapy/Procedure

14	Therapeutics 08/2022 - 03/2002
4	Transplantation 01/2022 - 08/2003
4	Hematopoietic Stem Cell Transplantation 01/2020 - 11/2002
3	Drug Therapy (Chemotherapy) 12/2020 - 01/2002
2	Duration of Therapy 02/2022 - 01/2020
2	Liver Transplantation 01/2019 - 01/2012
2	Highly Active Antiretroviral Therapy (HAART) 11/2018 - 10/2012
1	Home Nursing (Nursing, Home) 12/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Institutionalization (Institutionalized Persons) 12/2020
1	Chemoprevention 11/2020
1	Artificial Respiration (Mechanical Ventilation) 08/2020
1	Cell Transplantation 08/2020
1	Organ Transplantation 01/2020
1	Antibiotic Prophylaxis 04/2019